Medtronic plc (BVMF:MDTC34)

Market Cap	688.55B +1.7%
Revenue (ttm)	187.22B +5.3%
Net Income	25.66B +11.1%
EPS	19.88 +13.0%
Shares Out	n/a
PE Ratio	26.83
Forward PE	17.54
Dividend	5.68 (2.08%)
Ex-Dividend Date	Dec 23, 2025

Volume	1,300
Average Volume	92
Open	265.68
Previous Close	270.30
Day's Range	265.68 - 273.53
52-Week Range	228.15 - 277.20
Beta	0.72
RSI	60.33
Earnings Date	Feb 17, 2026

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1949
• Employees: 95,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: MDTC34

Financial Performance

In fiscal year 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial numbers in USD